ClinicalTrials.gg
Enrolling by invitationNCT07332559Updated Jan 12, 2026

Task-Oriented Writing Intervention for Preschoolers

An interventional study of Task-Oriented Writing Intervention and Conventional Fine Motor Training in Preschool Child and Handwriting, sponsored by Taipei Medical University WanFang Hospital. Enrolling by invitation at 1 site in Taiwan. Open to participants aged 4 Years to 6 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-12.

Sponsored by Taipei Medical University WanFang Hospital · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 1 year 7 months after the study started (first participant enrolled May 2024, registered Dec 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
4 Years to 6 Years
Sex
All
01

Study summary

This study investigates the effectiveness of a task-oriented writing intervention in improving writing performance among preschool children. The intervention is designed to enhance early writing-related abilities through structured, goal-directed writing tasks that reflect functional and meaningful activities.

Eligible preschool children will participate in a series of task-oriented writing sessions delivered in a structured learning environment. Writing performance will be assessed before and after the intervention to examine changes associated with participation in the program.

Findings from this study are expected to provide evidence to support the use of task-oriented writing interventions in early childhood educational and therapeutic settings.

02

Conditions studied

  • Preschool Child
  • Handwriting
03

In context

Lead sponsor

Taipei Medical University WanFang Hospital is the lead sponsor of 201 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
4 Years to 6 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria: Preschool children diagnosed with sensory integration dysfunction.

Exclusion Criteria:Children who are unable to follow simple instructions required for participation in the intervention.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
36 participants (estimated)

Study arms

  • Experimental
    Task-Oriented Writing Intervention

    Behavioral: Task-Oriented Writing Intervention

  • Active comparator
    Control group

    Behavioral: Conventional Fine Motor Training

Interventions

  • BehavioralTask-Oriented Writing Intervention

    The task-oriented writing intervention consists of structured, goal-directed writing activities designed to support the development of writing performance in preschool children. The intervention focuses on functional writing tasks that are meaningful and relevant to daily learning contexts. Sessions are delivered in a structured educational setting and emphasize active participation and practice.

  • BehavioralConventional Fine Motor Training

    Participants in the control group receive conventional fine motor training focusing on hand function, coordination, and activities relevant to daily participation, without the task-oriented writing intervention.

06

What researchers measure

Primary outcomes

  1. The Berry-Buktenica Developmental Test of Visual-Motor Integration

    Time frame: Baseline (pre-intervention), immediately post-intervention, and 4 weeks after completion of the intervention

  2. Test of Visual Perceptual Skills-4th Edition

    Time frame: Baseline (pre-intervention), immediately post-intervention, and 4 weeks after completion of the intervention.

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started May 2024 (actual). Primary completion is estimated for Dec 2027, 43 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 29, 2025
First posted
Jan 12, 2026
StartActual
May 6, 2024
Primary completionEst.
Dec 31, 2027
CompletionEst.
Dec 31, 2028
Last update
Jan 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07332559
Responsible party
Sponsor
First posted
Jan 12, 2026
Start date
May 6, 2024
Primary completion
Dec 31, 2027 (estimated)
Completion
Dec 31, 2028 (estimated)
Last update
Jan 12, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion